West Pharmaceuticals stock drops 38% after ending glucose monitor contracts; CEO Eric Green says GLP-1 business will offset ...

Applied DNA Sciences exits DNA Tagging business segment. Workforce reduction and GMP site completion announced. Financial results for Q1 fiscal 2025 revealed ...

And a review study published in Nutrients showed that yerba maté may help support energy levels, aid in weight loss by ...

Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...

A high-resolution spatial map of the human hypothalamus makes it possible to identify specific cells, determine their exact ...

LifeVantage (LFVN) announced the completion of an international in vitro cell study that investigated the effects of its international ...

Scientists have created the most detailed map to date of the human hypothalamus, a crucial brain region that regulates body weight, appetite, sleep ...

Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 EPS, expectations were $1.85. Operator: Thank you for standing by. Welcome to ...

NEW YORK, NY (Feb. 5, 2025)--Columbia scientists have found specialized neurons in the brains of mice that order the animals to stop eating. Though many feeding circuits in the brain are known to play ...

SALT LAKE CITY - LifeVantage Corporation (NASDAQ:LFVN), a $271 million market cap player in the health and wellness sector with impressive 79% gross profit margins, today announced the successful ...